Currently, ALC's 12-month EPS stands at $1.31, according to the most recent financial reports. During 2025, ALC reported a per-share earnings of $1.99, which shows a decline compared to the EPS of $2.06 recorded in 2024. ALC recorded an EPS of $0 for the quarterly period ending on Jun 30, 2026.
In 2025, Alcon's earnings per share was $1.99, a decline of 3.4% from $2.06 in 2024. Over the quarter ending Jun 30, 2026, the earnings per share came in at $0, reflecting a 100% decline compared to the same quarter a year earlier. As of June 2026, the TTM EPS is $1.31. During 2024, the annual earnings per share was $2.06, representing an increase of 4% compared to 2023.
In the past 12 months, Alcon has recorded an earnings per share growth rate of -100% (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 43% per year.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| BSX Boston Scientific Corp | 17.39 | 55.6% | 63.3% | N/A |
| COO Cooper Companies Inc | 18.57 | -4.6% | -1.2% | 9.2% |
| ZBH Zimmer Biomet Holdings Inc | 22.3 | -20% | 47.9% | N/A |
| MDT Medtronic Plc | 22.74 | 3.3% | 9.8% | 6.9% |
| SYK Stryker Corp | 29.01 | 8% | 10.9% | 14.8% |
| ABT Abbott Laboratories | 33.1 | -51.4% | -1.8% | 8.2% |
| ISRG Intuitive Surgical Inc | 47.8 | 22.3% | 29.1% | 21.5% |
| ALC Alcon Inc | 48.09 | -3.4% | 43% | N/A |
| EW Edwards Lifesciences Corp | 49.01 | -73.6% | -9.2% | 6.9% |
| BDX Becton Dickinson & Company | 56.44 | -0.9% | -0.6% | 16.2% |
| TFX Teleflex Incorporated | N/A | -1,462.4% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.